Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2025-12-27 @ 5:16 AM
Study NCT ID:
NCT05858450
Status:
COMPLETED
Last Update Posted:
2024-09-20
First Post:
2023-05-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-12
Completion Date Type:
ACTUAL
First Submit Date:
2023-05-11
First Submit QC Date:
None
Study First Post Date:
2023-05-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-05-06
Results First Submit QC Date:
None
Results First Post Date:
2024-09-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-06
Last Update Post Date:
2024-09-20
Last Update Post Date Type:
ACTUAL